| lisdexamfetamine / Generic mfg. |
| Completed | 4 | 42 | US | Vyvanse, lisdexamfetamine dimesylate | Kimberley Lakes, Shire | Attention Deficit/Hyperactivity Disorder | 09/09 | 09/09 | | |
NCT00889915: Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study) |
|
|
| Completed | 4 | 228 | US | Methylphenidate transdermal system, Daytrana, Lisdexamfetamine dimesylate, Vyvanse, Osmotic-release oral system methylphenidate (OROS MPH), Concerta, Mixed amphetamine salts extended release, Adderall XR | Duke University, National Institute of Mental Health (NIMH) | Attention Deficit Disorder With Hyperactivity | 12/09 | 12/09 | | |
NCT00573534: Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse |
|
|
| Completed | 4 | 8 | US | Vyvanse, Lisdexamphetamine is marketed as Vyvanse | New York State Psychiatric Institute | Attention Deficit Hyperactivity Disorder | 01/10 | 03/10 | | |
NCT00753012: Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults |
|
|
| Completed | 4 | 24 | US | Lisdexamfetamine, Vyvanse | Massachusetts General Hospital, Shire | Attention Deficit Hyperactivity Disorder (ADHD) | 03/11 | 03/11 | | |
NCT01017263: Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity |
|
|
| Terminated | 4 | 14 | US | Lis-dexamphetamine, Vyvanse, LDX | Duke University, Shire | Attention Deficit Hyperactivity Disorder, Glucose Intolerance, Obesity | 08/12 | 08/12 | | |
NCT02204410: Omega-3 Supplementation to ADHD Medication in Children |
|
|
| Completed | 4 | 21 | US | Omega-3 Fatty Acid, Fish Oil, Nordic Naturals Pro-Omega Junior Omega-3 Fatty Acid, Nordic Omega-3 Fishies, ADHD Medication, Stimulant, Concerta, Ritalin, Focalin, Vyvanse, Adderall, Dexedrine, Amphetamine, Methylphenidate, Stratterra, Tenex | Massachusetts General Hospital | Attention Deficit Hyperactivity Disorder, Deficient Emotional Self-Regulation | 05/16 | 08/16 | | |
NCT02675400: Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too) |
|
|
| Completed | 4 | 19 | US | Vyvanse, lisdexamfetamine dimesylate, Behavioral Parent Training, BPT, Methylphenidate, MPH | Seattle Children's Hospital | Attention Deficit/Hyperactivity Disorder (ADHD) | 08/18 | 08/18 | | |
